­
­
­
­

Inventi Impact: Obstetrics and Gynaecology

Articles

  • Inventi:hog/23861/17
    Validation of Nomograms for Survival and Metastases after Hysterectomy and Adjuvant Therapy in\nUterine Cervical Cancer with Risk Factors
    01-Jan-1970 Research 2017 : October - December
    Won Sup Yoon, Dae Sik Yang, Jung Ae Lee, Nam Kwon Lee, Young Je Park, Chul Yong Kim, Nak Woo Lee, Jin Hwa Hong, Jae Kwan Lee, Jae Yun Song

    Background.Three nomogrammodels for early stage uterine cervical cancer have been developed (KROG 13-03 for overall survival\n[OS], SNUH/AMC for disease-free survival [DFS], and KROG 12-08 for distant metastases-free survival [DMFS]) after radical\nhysterectomy (RH) and pelvic lymph node dissection (PLND). This study aimed to validate these models using our cohort with\nadjuvant radiotherapy. Methods. According to the eligibility criteria of nomogram studies, patients were enrolled in Group A (

    How to Cite this Article
    CC Compliant Citation: Won Sup Yoon, Dae Sik Yang, Jung Ae Lee, et al., â??Validation of Nomograms for Survival and Metastases after\nHysterectomy and Adjuvant Therapy in Uterine Cervical Cancer with Risk Factors,â? BioMed Research International, vol. 2017, Article ID\n2917925, 9 pages, 2017. doi:10.1155/2017/2917925, http://creativecommons.org/licenses/by/4.0/.
    Download Full Text